Introduction
The endothelium plays a central role in vascular physiology, and endothelial dysfunction is intimately associated with vascular disease. [1] [2] [3] Endothelial dysfunction is often preceded by 'activation', characterized by the induction of proinflammatory signalling cascades and increased expression of vascular adhesion molecules on the endothelial cell surface. These events stimulate the recruitment of leucocytes to the arterial wall and the initiation of the inflammatory and immune processes that promote atheroma initiation and progression in humans and mice.
. The NECD interacts with membrane-bound ligands of the Delta-like (Dll1, Dll3, and Dll4) and Jagged (Jag1 and Jag2) families expressed on adjacent cells, triggering a series of cleavages in the NICD. Cleavage by the c-secretase complex releases NICD, which is then translocated to the nucleus. 8 In the nucleus, the NICD forms a complex with the recombination signal binding protein for immunoglobulin kappa J region (RBPJ)/ CSL effector transcription factor, resulting in activation of target genes, including those encoding the Hes and Hey families of transcriptional repressors. 9 Notch pathway elements are expressed broadly in the vascular endothelium and smooth muscle from early developmental stages. 10, 11 Their function is to maintain proper artery, capillary, and vein organization 12 and to regulate vascular smooth muscle cell differentiation and the response to vascular injury. 11, 13 Notch pathway elements are activated after experimentally induced vascular injury, 14, 15 and blockade of Notch signalling compromises vascular repair and pathological remodeling, [16] [17] [18] underscoring the importance of this pathway in maintaining vascular wall homeostasis.
We found multiple components of the NOTCH pathway to be upregulated in human atherosclerotic lesions and in the hyperlipidemic apolipoprotein E-knockout (ApoE À/À ) mouse model of atherosclerosis, suggesting an important function for NOTCH signalling during the chronic inflammation underlying atherosclerosis. To study the contribution of NOTCH signalling to this process, we combined genetic models of systemic [heterozygous RBPJ mutant mice (RBPJ þ/À ) and heterozygous mouse model. We show that canonical Notch deficiency in the endothelium of cholesterol-fed ApoE À/À mice decreases atherosclerosis, secretion of inflammation-related factors, and leucocyte recruitment to the arterial wall. Transcriptome analysis indicates that endothelial Notch-RBPJ signalling favours disease progression during atherosclerosis through a process largely driven by nuclear factor-jB (NF-jB)-mediated inflammation. We also show that N1ICD binds to both IKKa and NF-jB-p65, and that its interaction with NF-jB-p65 is enhanced by proinflammatory signals and promotes nuclear localization in endothelial cells. We propose that synergy between Notch and NF-jB signalling in the endothelium ensures an adequate inflammatory response by promoting robust and sustained bidirectional target gene transactivation. Given the strong activation of NOTCH signalling in atherosclerotic coronary arteries of CAD patients, attenuating NOTCH signalling in the endothelium represents a potential therapeutic strategy for CAD.
Methods
Materials and Methods are available in the Supplementary material online.
Results

Enhanced expression of Notch pathway components in human and mouse atherosclerotic lesions
To explore the clinical relevance of the Notch pathway during atherosclerosis we examined the expression of NOTCH pathway components in human atherosclerotic coronary arteries. Western blot analysis revealed markedly increased protein levels of NOTCH1 (full-length and cleaved), JAG1, and HES1 in atherosclerotic coronary arteries from coronary artery disease (CAD) patients ( Figure 1A) . qRT-PCR analysis revealed corresponding increases in NOTCH1, JAG1, and HES1 mRNA expression ( Figure 1B ). These data highlight the clinical importance of Notch signalling activation in CAD. Similar results were obtained upon examination of aortic-root crosssections from C57BL/6 control mice and ApoE À/À mice fed a highcholesterol diet (HCD) for 6 weeks. Thus, Jagged1, Notch1, NICD, and Hes1 were all up-regulated in the endothelium of ApoE À/À mice at atherosclerotic and non-atherosclerotic plaque sites ( Figure 1C-F) . The expression of Dll4, Notch2, Notch4, and Hey1 was increased although more readily within cells located inside the atherosclerotic plaque (Supplementary material online, Figure S1A -D). Exposing mouse ApoE À/À aortic endothelial cells (MAEC) to the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-a) strongly up-regulated the expression of Notch1-4, Jag1, Hes1, Hey1, and Hey2 mRNA, but not Dll4 (Supplementary material online, Figure S1E ). Western blot confirmed TNF-a-induced increases in Jag1 and Hes1 protein expression (Supplementary material online, Figure S1F ). Oxidation of low-density lipoproteins (LDL) is a primary factor triggering atherogenesis. 19 To examine the effect of ox-LDL in vitro, MAECs were exposed to a subapoptotic concentration of ox-LDL (25 lg/mL) for 24 h. This treatment resulted in a sharp increase of Notch1-4, Jag1, Dll4, Hes1, and Hey2 mRNA, but not Hey1 (Supplementary material online, Figure S1G ). Thus the expression of several Notch pathway genes in MAEC is up-regulated by pro-inflammatory/pro-atherogenic factors TNF-a and ox-LDL, mimicking the effect of the HCD. ; Cdh5-Cre ERT mice with respect to controls (P < 0.01; Figure 2D and E).
Inactivation of endothelial
To quantify disease progression, atherosclerotic lesions were grouped into three categories of increasing severity, as previously described. ; Cdh5-Cre ERT mice contained fewer apoptotic ; Cdh5-Cre ERT mice (6-8 weeks old) induced with 4-hydroxy-tamoxifen on five consecutive days and fed a HCD for 6 weeks.
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Endothelial Notch inactivation impairs leucocyte rolling and homing and vascular adhesion molecule expression
To investigate the effect of Notch on myeloid cell recruitment we monitored leucocyte adhesion and immune-cell composition in plaques. Atherosclerotic lesions of ApoE À/À ; RBPJ flox/flox ; Cdh5-Cre ERT mice had a below-control macrophage content (P < 0.05; Figure 2H -J and Supplementary material online, Figure S4A and B) but a normal CD3 þ T cell content (Supplementary material online, Figure S4C and D). Flow cytometry analysis of the whole aorta revealed a decrease of Gr1
; Cdh5-Cre ERT mice with respect to their WT ApoE À/À ; RBPJ flox/flox counterparts (Supplementary material online, Figure S4E ). However with regard to the total number of circulating cells, the total number of circulating T cells Figure S4F ). Moreover, the proportion of Lin À ckit þ sca1 þ bone marrow (BM) hematopoietic stem cells was also relatively similar in both groups (Supplementary material online, Figure S4G ). These data suggest that the paucity of macrophages in the plaques of ApoE À/À ; RBPJ flox/flox ; Cdh5-Cre ERT mice is due to reduced leucocyte recruitment rather than impaired production of circulating cells.
To examine the role of endothelial Notch signalling in leucocyte rolling, we grafted BM from ApoE À/À ; Mafia transgenic mice into
; Cdh5-Cre ERT mice and ApoE À/À ; RBPJ flox/flox littermates, to allow easy identification of GFP-positive circulating monocytes and neutrophils. 26 After total reconstitution, mice were fed a HCD for 3 weeks, and the carotid arteries were examined by intravital microscopy ( Figure 3A) . ; Cdh5-Cre ERT mice or littermate controls; fewer leucocytes adhered to the RBPJ-deleted MAEC than to controls ( Figure 3G) . Moreover, the impaired leucocyte adhesion correlated with low Icam1 and Vcam1 expression in TNF-a-stimulated MAEC ( Figure 3H ). Consistent with these data, treatment with the c-secretase inhibitor c-secretase/Notch signalling pathway inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT) 27 decreased leucocyte adhesion to bovine aortic endothelial cells (BAEC) ( Figure 3I ) and reduced Icam1 and Vcam1 transcription ( Figure 3J ). Taken together, our data suggest that Notch signalling in the endothelium promotes myeloid leucocyte recruitment by sustaining the expression of Icam1 and Vcam1. ; Cdh5-Cre ERT mice ( Figure 4 and Supplementary material online, Table S2 ). A selection of 81 differentially expressed transcripts associated to six biological functions defined by Gene Ontology (GO) are shown in Figure 4A . Many up-regulated genes were associated with cell-to-cell interactions and survival, such as those encoding tight junction or gap-junction proteins like Tjp1, Cldn25, and Gjc1 and the survival genes Rictor, Akt3, and Bcl2, perhaps reflecting changes of vascular permeability. Figure S5A and B), suggesting that endothelial barrier function was not impaired. In contrast, there was a severe down-regulation of genes implicated in cellular processes related to inflammation ( Figure 4A) , notably those required for leucocyte-endothelium interaction and leucocyte extravasation. Thus chemokine receptors (Cxcr2), cellular mediators of monocyte/ macrophage activation like Ccl2 (MCP1), Ccl7, Ccl12, Ccl4, Cxcl1, and Ccl3 ( Figure 4A) , and leucocyte adhesion proteins like P-Selectin (Selp) and E-Selectin (Sele) were sharply decreased. These latter factors are expressed on activated endothelial cells shortly after cytokine activation by tissue macrophages. Other genes involved in immune cell movement and trafficking, such as integrin ligands Vcam1 and Icam1 were also downregulated ( Figure 4A) , consistent with our prior in vitro observations ( Figure 3H and J) . Attenuation of the global inflammatory response was further evidenced by decreased expression of classical mediators of immunity, including interleukins and their corresponding receptors (Il1b/ Il1r2, Il6/Il6r, Tnf/Tnfrsf1b). Importantly, the aortic arch of ApoE À/À ;
Endothelial RBPJ ablation attenuates the atherogenic inflammatory programme
RBPJ flox/flox
; Cdh5-Cre ERT mice showed significant down-regulation of members of pathways previously associated with atherosclerosis, such as prototypical components of the NF-jB signalling pathway (RelB, Nfkbie, Nfkbid, Nfkb2, and Nfkbia), matrix metalloproteases (including Mmp2 and Mmp14, and Timp1), and Toll-like receptors pathways (Tlr1, Tlr2, and Tlr6; Figure 4A ). Interestingly, among the up-regulated genes important for the inflammatory response, Tgfb3 and its receptor Tgfb3r were reported previously in relation to atherosclerosis development in ApoE À/À mice. 28 These findings were confirmed by canonical pathways analysis (Supplementary material online, Table S2 ). For example, the NF-jB, IL6, acute phase inflammatory response, and Toll-like receptor pathways were all significantly down-regulated, whereas Tgfb was up-regulated ( Figure 4B) . Changes in the expression of several key genes implicated in endothelial activation and inflammation were validated by qRT-PCR ( Figure 4C ) and/or immunohistochemistry ( Figure 4D-F) . The RNA-seq also detected differential modulation of genes associated with cellular growth and proliferation; for example, the cell-cycle inhibitor CDKN1A (p21) was down-regulated, whereas CDKN1B (p27) was up-regulated ( Figure 4A and Supplementary material online, Table  S1 ), consistent with CDKN1A being atherogenic and CDKN1B atheroprotective. 29 Figure S5C and D). Taken together, the RNA-seq data analysis indicates that endothelialspecific Notch ablation suppresses the proinflammatory genetic programme associated with atherosclerosis.
Notch interacts with NF-jB in endothelial cells and facilitates NF-jB nuclear localization
Many of the putative RBPJ target genes identified by RNA-seq are also targets for (NF-jB; http://www.bu.edu/nf-kb/gene-resources/target-genes/ (8 August 2016, date last accessed)). NF-jB is a family of transcription factors whose predominant form, p65/p50, is maintained in an inactive state in the cytoplasm through interaction with inhibitor of kappa light polypeptide gene enhancer in B cells (Ikbka). 30 In response to inflammatory stimuli elicited by cytokines such as TNF-a, Ikbka is phosphorylated by the IKK complex and releases p65/p50, which translocates to the nucleus and activates transcription of genes containing kB sites in their promoter. 30 Given that endothelial NF-jB signalling activation is critical for inflammation and atherogenesis in mice, 24 we hypothesized that Notch might act upstream of, or in parallel with, NF-jB to regulate common target genes. Studies in different cellular systems have determined that the physical interaction between N1ICD and NF-jB facilitates NF-jB nuclear translocation and/or retention. [31] [32] [33] [34] [35] [36] To determine if N1ICD promotes NF-jB nuclear translocation in endothelial cells, we monitored the levels of nuclear and cytoplasmic NF-jB-p65 protein over time in response to TNF-a. After 30 min in the presence of TNF-a the proportion of nuclear NF-jB-p65 staining was markedly reduced (P < 0.01) in MAEC ( Figure 5A and B) , whereas the proportion of nuclear and cytoplasmic staining was higher (P < 0.05), suggesting that p65 nuclear translocation is blocked or delayed in MAEC lacking RBPJk. In addition, analysis of nucleo-cytoplasmic fractions by western blot indicated that TNF-a-stimulated NF-jB-p65 nuclear accumulation after 30 min was 2.5-fold increased in ApoE À/À ; RBPJ flox/flox MAEC compared to two-fold in ApoE N1ICD is known to facilitate NF-jB nuclear translocation in cancer cells and valve aortic interstitial cells by interacting with the IKK complex. [34] [35] [36] To determine if N1ICD-IKKa interaction increases the nuclear presence of NF-jB-p65 in endothelial cells, we immunoprecipitated N1ICD from porcine aortic endothelial cells (PAEC) overexpressing a myc-tagged version of N1ICD. 27 IKKa and N1ICD were coimmunoprecipitated from untreated PAEC N1ICD cells, and this interaction was enhanced by treatment with TNF-a ( Figure 5D ). Myc-tagged N1ICD from PAEC also co-immunoprecipated NF-jB-p65/p50 ( Figure  5E) , and TNF-a stimulation also increased N1ICD binding to NF-jB-p65 and the amount of immunoprecipated NF-jB in HUVEC ( Figure 5F ).
Taken together, these results indicate that N1ICD can bind to both IKKa and NF-jB-p65. Its interaction with NF-jB-p65 is enhanced by proinflammatory signals and promotes NF-jB nuclear localization in endothelial cells.
N1ICD and NF-jB coactivate the inflammatory response in endothelial cells
An anticipated functional outcome of increased nuclear NF-jB-N1ICD complex formation is that the transactivation of target genes common to both NFjB and N1ICD is more sustained or prolonged. Treating HUVEC with TNF-a resulted in marked induction of VCAM-1, ICAM-1, SELE, and NFKB2 and NFkBIa expression ( Figure 6A ). This effect was almost completely abolished by pre-treating cells with the chemical NFjB inhibitor BAY-11-7082 (BAY-11) ( Figure 6A ). TNF-a also increased the expression of JAG1 and HEY1, and this effect was blocked by BAY-11 ( Figure 6A) , suggesting that the expression of TNF-a-induced Notchpathway genes is dependent on NF-jB activation. These results were confirmed by western analysis of JAG1 and VCAM1 ( Figure 6B ). BAY-11 only partially reduced JAG1 levels, suggesting that JAG1 protein levels depend on additional factors ( Figure 6B ). These data suggest NF-jB activation is required for the TNF-a-mediated stimulation of target gene transcription by both NF-jB and NOTCH pathways. We next examined the effect of RBPJ genetic disruption upon TNF-a stimulation in MAEC. In ApoE À/À MAEC, TNF-a sustains the mRNA and protein expression of Notch pathway components (Notch1, Notch2, Notch4, Jag1, Dll4, Hes1, Hey1, and Hey2) and Vcam1, Icam1 ( Figure 3H Figure S6E and F). Accordingly, NFjB luciferase reporter activity increased 3.5-fold in BAEC in response to TNF-a, and this effect was reduced to two-fold by pre-treating with DAPT ( Figure 6E ). These data suggest that Notch activation is required for TNF-a-stimulated expression of NF-jB and Notch target genes. To determine if increased NICD-RBPJ signalling can activate NF-jB independently of TNF-a, we cultured HUVEC on plastic dishes coated with the extracellular domain of the NOTCH ligand JAG1. JAG1 ligand stimulation induced the NOTCH target genes DLL4, JAG1, HES1, and HEY1 as well as several NF-jB target genes, including VCAM1, ICAM1, SELE, NFKB2, and NFKBIa ( Figure 6F ), indicating that NOTCH activation by JAG1 can lead to the up-regulation of NF-jB target genes. To determine whether the effects of JAG1 and TNF-a were additive, we cultured HUVEC with TNF-a alone or together in presence of immobilized JAG1 extracellular domain. Although NFKB2 was not affected, a combination of TNF-a and JAG1 induced an average two-fold increase in the activation of the NOTCH and NF-jB target genes JAG1, HEY1, ICAM1, VCAM1, SELE, and NFKBIa compared with the effect of TNF-a alone ( Figure 6G) . These results suggest that the effects of TNF-a and JAG1 are additive. Taken together, our data indicate that TNF-a-stimulated transcription of NF-jB and NOTCH target genes requires the concerted activation of NICD-RBPJ and NF-jB signalling.
Discussion
In this study we addressed the role of canonical (RBPJ-mediated) Notch signalling in the adult endothelium and identified an important and unexpected pro-atherogenic Notch function in atherosclerosis. We find, consistent with a prior study 38 that Notch signalling components are up-regulated in luminal ECs of human atherosclerotic plaques, supporting a role for this developmental pathway in human CAD. We demonstrate that endothelial Notch inactivation slows the progression of atherosclerosis in ApoE À/À mice. Notch signalling activation is required for the inflammatory response elicited in the endothelium, but persistent activation in vivo is ultimately detrimental because it results in the chronic inflammatory process underlying atheroma plaque build-up. Previous models of artery injury and studies in endothelial cell cultures have pointed to a protective role of the Notch pathway in atherosclerosis. 39, 40 More recently, Notch pathway gene expression was found to be down-regulated in C57/BL6 mice on short-term high fat diet and in human aortic endothelial cells (HAEC) exposed to ox-PAPC or inflammatory cytokines. 41 This effect was linked to increased monocyte binding and diet-induced atherosclerosis in L-sIDOL mice 42 with heterozygous deletion of Notch1. 41 These contrasting data may reflect differences in model systems and experimental conditions (short-term vs. longterm diets; acute vs. chronic inflammation; different origins of the endothelial vascular bed and inter-individual variation) and the complexity of Notch signalling functions, canonical or non-canonical, which are highly context dependent.
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A pro-atherogenic effect of canonical Notch signalling in the endothelium is supported by the RNA-seq data. We detected significant downregulation of adhesion molecules, remodelling enzymes, and proinflammatory pathways in ApoE À/À ; RBPJ flox/flox ; Cdh5-Cre ERT mice, consistent with lower incidence of atherosclerosis and the requirement of endothelial Notch signalling for the inflammatory response. MMPs weaken the arterial wall and contribute to destabilization and rupture of atherosclerotic plaques. 43 Chemokines and their receptors support leucocyte arrest on the endothelium, form chemotactic gradients that promote qRT-PCR analysis in HUVEC plated for 24 h on JAG1-coated plates and exposed to TNF-a for 8 h. One of two independent experiments, each with three biological replicates is shown. For (A, C, E, F, and G), data are means 6 SEM. *P < 0.05; **P < 0.01; ***P < 0.001; n.s., non significant. and TLRs are all implicated in the inflammatory response. 45 TLRs recognize pathogens and mediate signalling pathways important for host defence and their effects are not limited to inflammatory cells because they can also alter the behaviour of resident vascular cells. 46 In summary, our RNA-seq data suggest that the inactivation of RBPJ in the endothelium negatively impacts key inflammatory processes involved in atherosclerosis progression. The NF-jB pathway was prominently down-regulated after endothelial RBPJ deletion. NF-jB is a master regulator of inflammatory responses, both in the initial stages of inflammation and in the resolution phases. 47, 48 Moreover, NF-jB regulates atheroma formation 48, 49 and a signalling mechanism driving atherosclerotic plaque progression in the endothelium. 24 A complex and incompletely understood interplay between Notch and NF-jB has been described in several cell types and contexts, including B cell differentiation, inflammation, injury, and cancer. Depending on the situation, this interplay can lead to either activation or repression of gene transcription. 50 In the context of inflammation, Notch and NF-jB interaction leads ultimately to transcriptional activation. For example, cooperation between Notch and NF-jB in macrophages is essential for the expression of interleukins 51, 52 and inflammatoryassociated molecules 53 and for macrophage activation. [54] [55] [56] Mechanistically, this synergism has been shown to occur through protein-protein interaction in the cytoplasm that facilitates shuttling to the nucleus [34] [35] [36] or through protein-protein interaction in the nucleus that promotes nuclear retention. 33 Moreover, N1ICD binding to NF-jB has been shown to stabilize NF-jB and enhance its binding to target gene promoters. 31, 32 Manipulating Notch and NF-jB activities allowed us to extend many of these findings to endothelial cells by establishing that the nuclear content of NF-jB-p65 is markedly below normal in endothelial cells lacking RBPJ. This implies that RBPJ and NF-jB interact functionally, consistent with findings in macrophages and other cell systems.
31-34,36,57 RBPJ and NF-jB-p60 may interact through N1ICD, since N1ICD can physically bind to NF-jB-p60 ( Figure 5E and F) . Future studies combining ChIP-seq with RNA-seq should shed light on the mechanism of transcriptional coregulation and identify the full repertoire of genes controlled by Notch and/or NF-jB in endothelial cells. Taken together, our findings support a model of tight integration between the NF-jB and Notch pathways early upon TNF-a stimulation, in which N1ICD acts as a transcriptional co-factor of NF-jB and establishes an auto-amplification loop through Jag1 that heightens NF-jB signalling ( Figure 7) . Initially, NF-jB-dependent Jag1 induction in endothelial cells may be mediated by signals emanating from interacting mononuclear cells. Supporting this idea, cell surface expression of Jag1 in c-Rel-expressing cell monolayers functionally interacts with lymphocytes expressing the Notch1 receptor. [58] [59] [60] Given that Jag1 expression is widespread in immune cells and tissues, [58] [59] [60] signalling to Notch1-expressing endothelial cells is also likely. Subsequently, coactivation of Jag1 expression by Notch and NF-jB augments and sustains a subset of NF-jB-inducible genes that are Notch dependent. In a similar fashion, Jag1-mediated cross-amplification between TLR and Notch is required in primary macrophages for the early phases of TLR-induced gene expression and induction of Notch ligands that can modulate later phases of the TLR response. 60, 61 Moreover, feed-forward signalling between Jag1/Notch and NF-jB may constitute a 'priming' mechanism that ensures rapid propagation of the inflammatory response from locally athero-susceptible regions to the rest of the endothelium. The graded pattern of N1ICD expression, between athero-prone ApoE À/À and relatively athero-resistant C57/BL6 mice on one hand, and sites of atheroma formation in fat-fed ApoE À/À mice on the other ( Figure   1 ), suggests that N1ICD expression and disease progression are linked and that a Notch-dependent inflammatory programme precedes overt disease. This possibility could be examined in juvenile ApoE À/À mice, which experience low-level inflammation but show no signs of atheroma formation before 4 weeks of age. 62 Early detection of endothelial NOTCH activation may have prognostic value in atherosclerosis, given that endothelial activation and subsequent dysfunction contributes to atherosclerosis severity and progression. 2, [63] [64] [65] Moreover, strategies that aim to attenuate NOTCH signalling in the endothelium should be 
